NewLink reports updated phase I data for indoximod + chemotherapy to treat DIPG

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

According to data presented by NewLink, all 10 newly diagnosed DIPG patients in a phase I study demonstrated initial symptomatic improvement after treatment with indoximod and chemotherapy.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe

YOU MAY BE INTERESTED IN

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login